• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU.

作者信息

Blet Alice, de Roquetaillade Charles, Hartmann Oliver, Struck Joachim, Mebazaa Alexandre, Chousterman Benjamin Glenn

机构信息

Department of Anesthesiology and Critical Care, Hôpital Lariboisière, DMU Parabol, APHP.Nord, Paris, France.

Inserm U942 MASCOT, Université de Paris, Paris, France.

出版信息

Crit Care. 2020 Feb 28;24(1):69. doi: 10.1186/s13054-020-2794-x.

DOI:10.1186/s13054-020-2794-x
PMID:32111263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7048063/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a21/7048063/d1003f0d6188/13054_2020_2794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a21/7048063/d1003f0d6188/13054_2020_2794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a21/7048063/d1003f0d6188/13054_2020_2794_Fig1_HTML.jpg

相似文献

1
Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU.除乳酸外，连续生物肾上腺髓质素测量对入住重症监护病房的脓毒症患者预后的附加价值。
Crit Care. 2020 Feb 28;24(1):69. doi: 10.1186/s13054-020-2794-x.
2
[Intestinal barrier dysfunction and its related factors in patients with sepsis].[脓毒症患者的肠道屏障功能障碍及其相关因素]
Zhonghua Yi Xue Za Zhi. 2016 Nov 29;96(44):3568-3572. doi: 10.3760/cma.j.issn.0376-2491.2016.44.007.
3
A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock.早期预警评分与乳酸相结合以预测严重脓毒症/脓毒性休克住院患者转入重症监护病房的情况。
Korean J Intern Med. 2015 Jul;30(4):471-7. doi: 10.3904/kjim.2015.30.4.471. Epub 2015 Jun 29.
4
Which one is a better predictor of ICU mortality in septic patients? Comparison between serial serum lactate concentrations and its removal rate.在脓毒症患者中，哪一个是 ICU 死亡率的更好预测指标？连续血清乳酸浓度及其清除率的比较。
J Crit Care. 2018 Apr;44:51-56. doi: 10.1016/j.jcrc.2017.10.019. Epub 2017 Oct 17.
5
The influence of a change in septic shock definitions on intensive care epidemiology and outcome: comparison of sepsis-2 and sepsis-3 definitions.脓毒症休克定义的改变对重症监护流行病学和结局的影响：脓毒症 2 期和脓毒症 3 期定义的比较。
Infect Dis (Lond). 2018 Mar;50(3):207-213. doi: 10.1080/23744235.2017.1383630. Epub 2017 Sep 26.
6
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a pilot study.严重脓毒症和脓毒性休克患者活性氧的预后价值：一项初步研究。
Minerva Anestesiol. 2016 Dec;82(12):1306-1313. Epub 2016 Sep 9.
7
Plasma adrenomedullin in critically ill patients with sepsis after major surgery: A pilot study.重大手术后脓毒症重症患者的血浆肾上腺髓质素：一项初步研究。
J Crit Care. 2017 Apr;38:68-72. doi: 10.1016/j.jcrc.2016.10.017. Epub 2016 Oct 28.
8
[The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].[促肾上腺髓质素作为脓毒症预后和风险分层新生物标志物的研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Aug;20(8):452-5.
9
Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.降钙素原在社区获得性肺炎所致严重脓毒症和脓毒性休克患者中的预后价值。
Swiss Med Wkly. 2012 Mar 19;142:w13542. doi: 10.4414/smw.2012.13542. eCollection 2012.
10
Prognosis of patients excluded by the definition of septic shock based on their lactate levels after initial fluid resuscitation: a prospective multi-center observational study.基于初始液体复苏后乳酸水平对脓毒性休克定义排除的患者的预后：一项前瞻性多中心观察性研究。
Crit Care. 2018 Feb 24;22(1):47. doi: 10.1186/s13054-017-1935-3.

引用本文的文献

1
Recent advances of precision immunotherapy in sepsis.脓毒症精准免疫治疗的最新进展
Burns Trauma. 2025 Jan 13;13:tkaf001. doi: 10.1093/burnst/tkaf001. eCollection 2025.
2
Postoperative bioactive adrenomedullin is associated with the onset of ARDS and adverse outcomes in patients undergoing open thoracoabdominal aortic surgery.术后生物活性肾上腺髓质素与开胸胸腹主动脉手术后患者 ARDS 的发生和不良预后相关。
Sci Rep. 2024 Jun 4;14(1):12795. doi: 10.1038/s41598-024-63412-1.
3
Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department.

本文引用的文献

1
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.循环肾上腺髓质素评估脓毒症器官衰竭的存活和可逆性：前瞻性观察性多国肾上腺髓质素和脓毒症及脓毒性休克-1 结局研究（AdrenOSS-1）。
Crit Care. 2018 Dec 21;22(1):354. doi: 10.1186/s13054-018-2243-2.
2
The Surviving Sepsis Campaign Bundle: 2018 Update.拯救脓毒症运动集束治疗：2018年更新版
Crit Care Med. 2018 Jun;46(6):997-1000. doi: 10.1097/CCM.0000000000003119.
3
The ten pitfalls of lactate clearance in sepsis.
在急诊科，测量循环生物肾上腺髓质素和 proenkephalin 对 COVID-19 和非 COVID-19 间质性肺炎患者 30 天死亡率风险预测的效用。
Medicina (Kaunas). 2022 Dec 15;58(12):1852. doi: 10.3390/medicina58121852.
4
Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study.生物活性肾上腺髓质素作为急诊科轻度至中度呼吸困难患者的预后生物标志物：一项观察性研究。
Intern Emerg Med. 2022 Mar;17(2):541-550. doi: 10.1007/s11739-021-02776-y. Epub 2021 Jun 26.
5
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study.生物活性肾上腺髓质素在德国新冠肺炎重症患者中的预后价值：一项观察性队列研究
J Clin Med. 2021 Apr 13;10(8):1667. doi: 10.3390/jcm10081667.
6
Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.循环生物活性肾上腺髓质素作为脓毒症、脓毒性休克和危重病的标志物。
Crit Care. 2020 Nov 4;24(1):636. doi: 10.1186/s13054-020-03351-1.
脓毒症中乳酸清除的十大陷阱
Intensive Care Med. 2019 Jan;45(1):82-85. doi: 10.1007/s00134-018-5213-x. Epub 2018 May 12.
4
The value of blood lactate kinetics in critically ill patients: a systematic review.危重症患者血乳酸动力学的价值：一项系统评价。
Crit Care. 2016 Aug 13;20(1):257. doi: 10.1186/s13054-016-1403-5.
5
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.评估全球医院治疗脓毒症的发病率和死亡率。当前的估计和局限性。
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72. doi: 10.1164/rccm.201504-0781OC.